Covered recipient · General Payments record
VICTORIA JOAN CURTISS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$4,996.43
- Reported across 306 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $449.14 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Antares Pharma, Inc. | $163.38 | 3 |
| Lilly USA, LLC | $69.39 | 4 |
| Novo Nordisk AS | $43.14 | 2 |
| ABBVIE INC. | $37.87 | 2 |
| Axsome Therapeutics, Inc. | $33.44 | 1 |
| Amgen Inc. | $31.23 | 2 |
| Exact Sciences Corporation | $28.79 | 2 |
| PFIZER INC. | $24.74 | 1 |
| SHIELD THERAPEUTICS INC | $17.16 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.44 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106976615 | CMS |
| ABBVIE INC. | $19.43 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106976617 | CMS |
| Amgen Inc. | $14.09 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117534918 | CMS |
| Amgen Inc. | $17.14 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117534920 | CMS |
| Antares Pharma, Inc. | $18.93 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146501673 | CMS |
| Antares Pharma, Inc. | $20.45 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146501678 | CMS |
| Antares Pharma, Inc. | $124.00 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146501682 | CMS |
| Axsome Therapeutics, Inc. | $33.44 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148418541 | CMS |
| Exact Sciences Corporation | $13.99 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114478674 | CMS |
| Exact Sciences Corporation | $14.80 | 10/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114478679 | CMS |
| Lilly USA, LLC | $14.04 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135984270 | CMS |
| Lilly USA, LLC | $14.74 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135984272 | CMS |
| Lilly USA, LLC | $19.65 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135992976 | CMS |
| Lilly USA, LLC | $20.96 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135988632 | CMS |
| Novo Nordisk Inc | $24.20 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100459052 | CMS |
| Novo Nordisk Inc | $18.94 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100527385 | CMS |
| PFIZER INC. | $24.74 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132010112 | CMS |
| SHIELD THERAPEUTICS INC | $17.16 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150147661 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.